Scinai Immunotherapeutics (SCNI) Capital Expenditures (2018 - 2026)
Scinai Immunotherapeutics (SCNI) reported Capital Expenditures of -$3000.0 for Q1 2026, up 66.67% on a YoY basis from -$1800.0 in Q1 2025, and little changed sequentially from -$3000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Capital Expenditures (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 9 years of Capital Expenditures data on file, last reported at -$3000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 66.67% year-over-year to -$3000.0; the trailing twelve-month figure through Mar 2026 stood at $9000.0 (up 80.0% YoY), and the FY2025 full-year result was $24000.0, up 100.0% from the prior year.
- Capital Expenditures held at -$3000.0 in Q1 2026, from -$3000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.4 million in Q4 2022 to a low of -$377000.0 in Q2 2023.
- A 5-year average of $162200.0 and a median of -$4000.0 in 2024 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 7542.86% in 2022, while the deepest fall reached 1900.0% in 2022.
- Tracing SCNI's Capital Expenditures over 5 years: stood at $1.4 million in 2022, then dropped by 25.82% to $1.0 million in 2023, then slumped by 97.69% to $24000.0 in 2024, then slumped by 112.5% to -$3000.0 in 2025, then changed by 0.0% to -$3000.0 in 2026.
- Business Quant data shows SCNI's Capital Expenditures at -$3000.0 in Q1 2026, -$3000.0 in Q2 2025, and -$9000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -377,000.00 |
| Jun 30, 2023 | -377,000.00 |